- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01643161
Guided Self-Help for Functional Neurological Symptoms
September 30, 2013 updated by: Kari A. Martin, Mayo Clinic
Guided Self-Help for Functional Neurological Symptoms: A Randomized Controlled Efficacy Trial
Functional (psychogenic or somatoform) symptoms are commonly observed in neurology clinics.
There is no known empirically validated treatment approach to functional symptoms.
Cognitive Behavioral Therapy (CBT) can be effective, but there are major obstacles to its provision.
The investigators will test the hypothesis that adding a CBT-based guided self-help (GSH) as compared to treatment as usual (TAU) improves patient outcomes.
Study Overview
Status
Terminated
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
33
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Arizona
-
Scottsdale, Arizona, United States, 85259
- Mayo Clinic
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Adult neurology outpatient with functional symptoms not largely explained by neurologic disease.
Exclusion Criteria:
- Unable to use the Guided Self-Help intervention, such as due to significant cognitive impairment or unable to comprehend English.
- Requires specialist psychiatric care.
- Has headache as the only symptom.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: TAU+GSH
Treatment As Usual plus Guided Self Help.
|
Communicating the diagnosis to the patient's primary care doctor and neurologist.
May include referrals for physical therapy or psychiatric evaluations, or referrals to community therapists or doctors.
A self-help workbook based on cognitive behavioral therapy, and four half-hour guidance sessions over a three-month period.
|
Active Comparator: TAU
Treatment AS Usual.
|
Communicating the diagnosis to the patient's primary care doctor and neurologist.
May include referrals for physical therapy or psychiatric evaluations, or referrals to community therapists or doctors.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
CGI
Time Frame: 3 months
|
Clinical Global Improvement scale score (much worse, worse, same, better, much better) rated by the patient.
|
3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
April 1, 2012
Primary Completion (Actual)
February 1, 2013
Study Completion (Actual)
August 1, 2013
Study Registration Dates
First Submitted
July 16, 2012
First Submitted That Met QC Criteria
July 17, 2012
First Posted (Estimate)
July 18, 2012
Study Record Updates
Last Update Posted (Estimate)
October 1, 2013
Last Update Submitted That Met QC Criteria
September 30, 2013
Last Verified
September 1, 2013
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 11-005721
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Functional Neurologic Disease
-
National Institute of Diabetes and Digestive and...CompletedIrritable Bowel Syndrome | Abdominal Pain | Constipation | Functional Colonic DiseasesUnited States, Canada
-
St Vincent's Hospital MelbourneCompletedFunctional Dyspepsia | Irritable Bowel Syndrome | Constipation - Functional | Faecal Incontinence | Functional Abdominal Pain Syndrome | Other Rome IV Functional Gastrointestinal DisordersAustralia
-
Karolinska InstitutetCompletedFunctional Dyspepsia | Functional Abdominal Pain | Irritable Bowel Syndrome (IBS) | Functional Gastrointestinal Disorders (FGID) | FGID According to the Rome III CriteriaSweden
-
University Medical Center GroningenZonMw: The Netherlands Organisation for Health Research and DevelopmentRecruitingIrritable Bowel Syndrome | Functional Gastrointestinal Disorders | Functional Abdominal Pain SyndromeNetherlands
-
Aarhus University HospitalKarolinska InstitutetRecruitingIrritable Bowel Syndrome | Functional Gastrointestinal Disorders | Functional Abdominal Pain SyndromeDenmark
-
Medical College of WisconsinCompletedDyspepsia | Irritable Bowel Syndrome | Functional Gastrointestinal Disorders | Functional Abdominal Pain SyndromeUnited States
-
Baylor College of MedicineUniversity of WashingtonRecruitingIrritable Bowel Syndrome | Functional Abdominal Pain | Functional Gastrointestinal Disorders | Functional Abdominal Pain Syndrome | Functional Bowel Disorder | Functional Abdominal Pain DisordersUnited States
-
Universidad de ColimaRecruitingFunctional Gastrointestinal Disorders | Functional Abdominal Pain Syndrome | Irritable Bowel Syndrome Variant of ChildhoodMexico
-
Boston Children's HospitalNationwide Children's HospitalCompletedFunctional Dyspepsia | Irritable Bowel Syndrome | Functional Abdominal Pain | Functional Gastrointestinal DisordersUnited States
-
University Hospital TuebingenSymbioPharm GmbHUnknownIrritable Bowel Syndrome | Functional Abdominal Pain SyndromeGermany
Clinical Trials on Treatment As Usual
-
Universitätsklinikum Hamburg-EppendorfCompletedPerioperative AnxietyGermany
-
South London and Maudsley NHS Foundation TrustCompletedAttention Deficit Hyperactivity DisorderUnited Kingdom
-
McMaster UniversityNot yet recruiting
-
Gaia AGRecruitingType 2 DiabetesGermany
-
Centre for Addiction and Mental HealthCompleted
-
King's College LondonUnknown
-
University Hospital, AkershusUniversity of OsloActive, not recruiting
-
University of IndianapolisUniversity of Missouri, Kansas City; Missouri State UniversityCompletedHypertension | Diabete Type 2United States
-
Universitat Jaume IConsorcio Hospitalario Provincial de CastellónCompletedDepression | AnxietySpain
-
Kuopio University HospitalUniversity of Oslo; University of Eastern Finland; City of KuopioRecruiting